Indivior PLC (OTCMKTS:INVVY – Get Free Report) shares passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $21.85 and traded as low as $21.64. Indivior shares last traded at $21.8455, with a volume of 8,100 shares traded.
Analyst Ratings Changes
Separately, Craig Hallum reaffirmed a “buy” rating and set a $50.00 price target on shares of Indivior in a research note on Friday, January 9th. One analyst has rated the stock with a Buy rating, According to MarketBeat.com, the company has an average rating of “Buy” and a consensus price target of $50.00.
View Our Latest Analysis on Indivior
Indivior Stock Down 1.8%
About Indivior
Indivior PLC is a specialty pharmaceutical company focused on developing and commercializing treatments for addiction and related disorders. The company’s core business centers on addressing opioid use disorder through a portfolio of branded pharmaceuticals and delivery systems designed to support long-term recovery. Indivior’s therapies are aimed at improving patient outcomes by reducing withdrawal symptoms and lowering the risk of relapse.
The company’s flagship product, Suboxone®, is a buprenorphine-naloxone sublingual film approved for the treatment of opioid dependence.
See Also
- Five stocks we like better than Indivior
- The gold chart Wall Street is terrified of…
- Elon Musk already made me a “wealthy man”
- Silver paying 20% dividend. Plus 68% share gains
- 1,500 Banks Just Handed the Fed Your Bank Account
- Trump Planning to Use Public Law 63-43: Prepare Now
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
